PRESS RELEASE published on 07/01/2025 at 13:15, 10 months 9 days ago Bio Usawa becomes partner for the commercialization of FYB201/ BioUcenta™ (ranibizumab) across Sub-Saharan Africa Bio Usawa partners with Formycon AG for the commercialization of FYB201/BioUcenta™ (ranibizumab) in Sub-Saharan Africa, expanding access to ophthalmic treatment for diabetic complications Formycon AG Commercialization FYB201 Bio Usawa BioUcenta
BRIEF published on 06/27/2025 at 15:56, 10 months 13 days ago Formycon Successfully Places EUR 70 Million Bond Amid High Demand Biosimilars Investor Interest Capital Market EUR 70 Million Formycon Bond
BRIEF published on 06/27/2025 at 15:56, 10 months 13 days ago Formycon place avec succès une obligation de 70 millions d'euros dans un contexte de forte demande Marché Des Capitaux Biosimilaires Intérêt Des Investisseurs Liaison Formycon 70 Millions D'euros
PRESS RELEASE published on 06/27/2025 at 15:51, 10 months 13 days ago Formycon increases bond volume following oversubscription – Bond 2025/2029 with a volume of EUR 70 million successfully and entirely placed Formycon AG successfully and entirely places EUR 70 million bond 2025/2029 following oversubscription, interest rate fixed at 7.00% p.a Formycon AG Interest Rate Oversubscription EUR 70 Million Bond 2025/2029
BRIEF published on 06/27/2025 at 15:50, 10 months 13 days ago Formycon obtient une obligation à taux variable de 70 millions d'euros Formycon AG Développement De Biosimilaires Émission Financière Obligation De 70 Millions D'euros Obligation À Taux Variable
BRIEF published on 06/27/2025 at 15:50, 10 months 13 days ago Formycon Secures EUR 70 Million Floating Rate Bond Formycon AG Financial Issuance Biosimilar Development EUR 70 Million Bond Floating Rate Bond
PRESS RELEASE published on 06/27/2025 at 15:45, 10 months 13 days ago EQS-Adhoc: Formycon successfully places an EUR 70 million senior unsecured floating rate bond Formycon AG successfully places EUR 70 million senior unsecured floating rate bond, issued with a maturity of 4 years, financed for biosimilar product portfolio development Formycon AG Financial Market Senior Unsecured Bond Biosimilar Products EUR 70 Million
BRIEF published on 06/26/2025 at 06:35, 10 months 15 days ago Teva commercialisera le biosimilaire Fymskina® de Formycon en Allemagne Allemagne Formycon Biosimilaire Teva Fymskina®
BRIEF published on 06/26/2025 at 06:35, 10 months 15 days ago Teva to Commercialize Formycon’s Biosimilar Fymskina® in Germany Germany Biosimilar Formycon Teva Fymskina®
PRESS RELEASE published on 06/26/2025 at 06:30, 10 months 15 days ago Teva becomes secondary commercialization partner for Formycon's Stelara® biosimilar FYB202 (ustekinumab) under the brand name Fymskina® in Germany Teva partners with Formycon for commercialization of Stelara biosimilar FYB202 (ustekinumab) as Fymskina in Germany. Market launch planned in Q3 2025 Biosimilar Formycon Teva Stelara Fymskina
Published on 05/11/2026 at 09:05, 2 hours 2 minutes ago Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Published on 05/11/2026 at 08:05, 3 hours 2 minutes ago Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/09/2026 at 01:30, 2 days 9 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/11/2026 at 10:05, 1 hour 2 minutes ago NOTAPE™ Tapeless & Seamless Zipper Pioneers Full-Lifecycle Green Innovation for Sustainable Manufacturing
Published on 05/11/2026 at 10:05, 1 hour 2 minutes ago Newton Cinema Makes Cannes Market Debut and Announces Salim Ahamed's Fifth Directorial Feature
Published on 05/11/2026 at 10:05, 1 hour 2 minutes ago VETRESKA Becomes Official Luxury Pet Accessories Partner of Formula 1 Driver Ollie Bearman
Published on 05/11/2026 at 10:00, 1 hour 6 minutes ago Original-Research: Antimony Resources Corp. (von GBC AG): BUY
Published on 05/11/2026 at 10:48, 19 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Published on 05/11/2026 at 10:48, 19 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 4 au 8 mai 2026
Published on 05/11/2026 at 09:16, 1 hour 51 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Published on 05/07/2026 at 19:15, 3 days 15 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 15 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote